This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Canine Signaling Lymphocytic Activation Molecule (SLAMF1), C-Fc
Product Overview
BioVenic's Recombinant Canine Signaling Lymphocytic Activation Molecule (SLAMF1), C-Fc is a recombinant protein expressed from Mammalian Expression System. Its predicted molecular weight is 52.2 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
Canine SLAMF1 (CD150) is a critical cell-surface glycoprotein expressed on activated lymphocytes, dendritic cells, and macrophages. It serves as a vital self-ligand receptor that modulates immune cell activation and cytokine production. Notably, SLAMF1 is the primary cellular receptor for the Canine Distemper Virus (CDV), facilitating viral entry and lymphotropism. Additionally, recent genomic studies link SLAMF1 variants to canine atopic dermatitis risk in breeds like French Bulldogs and Boxers, making it a key target for infectious disease and allergy research.
Shipping and Storage
This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.